<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34583328</PMID><DateCompleted><Year>2022</Year><Month>02</Month><Day>15</Day></DateCompleted><DateRevised><Year>2022</Year><Month>02</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1476-1645</ISSN><JournalIssue CitedMedium="Internet"><Volume>105</Volume><Issue>6</Issue><PubDate><Year>2021</Year><Month>Sep</Month><Day>27</Day></PubDate></JournalIssue><Title>The American journal of tropical medicine and hygiene</Title><ISOAbbreviation>Am J Trop Med Hyg</ISOAbbreviation></Journal><ArticleTitle>A Population-Based Cohort Study on Chronic Comorbidity Risk Factors for Adverse Dengue Outcomes.</ArticleTitle><Pagination><StartPage>1544</StartPage><EndPage>1551</EndPage><MedlinePgn>1544-1551</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4269/ajtmh.21-0716</ELocationID><ELocationID EIdType="pii" ValidYN="Y">tpmd210716</ELocationID><Abstract><AbstractText>The global burden of dengue is increasing against a background of rising global prevalence of chronic noncommunicable diseases (NCDs) and an epidemiological shift of dengue toward older age groups. The contribution of NCDs toward risk for adverse clinical and healthcare utilization outcomes was assessed in a national linked-database study. About 51,433 adult dengue cases between 2014 and 2015 were assessed for outpatient and inpatient claims data in Taiwan's National Health Insurance Research Database for the 30 days after their dengue diagnosis. A multivariable logistic regression with generalized estimating equations was used to estimate the probability of adverse dengue outcomes in patients with NCDs compared with dengue patients without underlying diseases. Rheumatoid arthritis and related disease were associated with the highest risk of hospitalization after dengue diagnosis (odds ratio: 1.78; 95% CI: 1.37-2.30), followed by stroke, chronic kidney disease (CKD), liver cirrhosis, asthma, coronary artery disease, chronic obstructive pulmonary disease, diabetes, congestive heart failure, hypertension, and malignancy. Chronic kidney disease and diabetes were associated with higher risks of hospitalization, intensive care unit (ICU) use, and all-cause mortality. After adjusting for socioeconomic status and other variables, the number of coexisting chronic diseases was associated with increasing risk of adverse dengue outcomes. Specific NCDs were associated with longer hospitalizations, ICU admission, and higher healthcare costs. Quantifying the risks of adverse dengue outcomes and health expenditures among dengue patients with preexisting NCDs provides insights for improved clinical management and essential inputs for health economic analyses on the cost-benefit of risk-based routine or catch-up immunization programs.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lien</LastName><ForeName>Chia-En</ForeName><Initials>CE</Initials><AffiliationInfo><Affiliation>Research Center for Epidemic Prevention, National Yang Ming Chiao Tung University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chou</LastName><ForeName>Yiing-Jenq</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>Institute of Public Health, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Office of the Deputy Superintendent, National Yang Ming Chiao Tung University Hospital, Yilan County, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Yi-Jung</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>Institute of Hospital and Health Care Administration, National Yang Ming Chiao Tung University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsai</LastName><ForeName>Theodore</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Takeda Vaccines, Cambridge, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Nicole</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Institute of Hospital and Health Care Administration, National Yang Ming Chiao Tung University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>09</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Trop Med Hyg</MedlineTA><NlmUniqueID>0370507</NlmUniqueID><ISSNLinking>0002-9637</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="N">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001249" MajorTopicYN="N">Asthma</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002908" MajorTopicYN="N">Chronic Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003715" MajorTopicYN="N">Dengue</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005355" MajorTopicYN="N">Fibrosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006333" MajorTopicYN="N">Heart Failure</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006402" MajorTopicYN="N">Hematologic Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029424" MajorTopicYN="N">Pulmonary Disease, Chronic Obstructive</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051436" MajorTopicYN="N">Renal Insufficiency, Chronic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>6</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>7</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>9</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>9</Month><Day>28</Day><Hour>20</Hour><Minute>31</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34583328</ArticleId><ArticleId IdType="pmc">PMC8641312</ArticleId><ArticleId IdType="doi">10.4269/ajtmh.21-0716</ArticleId><ArticleId IdType="pii">tpmd210716</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gubler DJ, 1998. Dengue and dengue hemorrhagic fever. Clin Microbiol Rev 11: 480&#x2013;496.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC88892</ArticleId><ArticleId IdType="pubmed">9665979</ArticleId></ArticleIdList></Reference><Reference><Citation>Brady OJ, Gething PW, Bhatt S, Messina JP, Brownstein JS, Hoen AG, Moyes CL, Farlow AW, Scott TW, Hay SI, 2012. Refining the global spatial limits of dengue virus transmission by evidence-based consensus. PLoS Negl Trop Dis 6: e1760.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3413714</ArticleId><ArticleId IdType="pubmed">22880140</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez AD, Murray CC, 2020. The global burden of disease, 1990&#x2013;2020. Nat Med 4: 1241&#x2013;1243.</Citation><ArticleIdList><ArticleId IdType="pubmed">9809543</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanaway JD. et al., 2016. The global burden of dengue: an analysis from the Global Burden of Disease Study 2013. Lancet Infect Dis 16: 712&#x2013;723.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5012511</ArticleId><ArticleId IdType="pubmed">26874619</ArticleId></ArticleIdList></Reference><Reference><Citation>
WHO
, 2019. Top 10 Threats to Global Health in 2019. Geneva, Switzerland: World Health Organization. Available at: https://www.who.int/news-room/feature-stories/ten-threats-to-global-health-in-2019. Accessed January 19, 2020.</Citation></Reference><Reference><Citation>World Health Organization, Special Programme for Research, Training in Tropical Diseases, World Health Organization. Department of Control of Neglected Tropical Diseases, World Health Organization. Epidemic, &amp; Pandemic Alert, 2009. Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control. Geneva, Switzerland: World Health Organization.</Citation></Reference><Reference><Citation>Ooi E-E, Goh K-T, Gubler DJ, 2006. Dengue prevention and 35 years of vector control in Singapore. Emerg Infect Dis 12: 887&#x2013;893.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3373041</ArticleId><ArticleId IdType="pubmed">16707042</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowe EK, Leo Y-S, Wong J, Thein T-L, Gan VC, Lee LK, Lye DC, 2014. Challenges in dengue fever in the elderly: atypical presentation and risk of severe dengue and hospital-acquired infection [corrected]. PLoS Negl Trop Dis 8: e2777.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3974675</ArticleId><ArticleId IdType="pubmed">24699282</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings DA, Iamsirithaworn S, Lessler JT, McDermott A, Prasanthong R, Nisalak A, Jarman RG, Burke DS, Gibbons RV, 2009. The impact of the demographic transition on dengue in Thailand: insights from a statistical analysis and mathematical modeling. PLoS Med 6: e1000139.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2726436</ArticleId><ArticleId IdType="pubmed">19721696</ArticleId></ArticleIdList></Reference><Reference><Citation>Shepard DS, Undurraga EA, Halasa YA, Stanaway JD, 2016. The global economic burden of dengue: a systematic analysis. Lancet Infect Dis 16: 935&#x2013;941.</Citation><ArticleIdList><ArticleId IdType="pubmed">27091092</ArticleId></ArticleIdList></Reference><Reference><Citation>Badawi A, Velummailum R, Ryoo SG, Senthinathan A, Yaghoubi S, Vasileva D, Ostermeier E, Plishka M, Soosaipillai M, Arora P, 2018. Prevalence of chronic comorbidities in dengue fever and West Nile virus: a systematic review and meta-analysis. PLoS One 13: e0200200.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6039036</ArticleId><ArticleId IdType="pubmed">29990356</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo C, Zhou Z, Wen Z, Liu Y, Zeng C, Xiao D, Ou M, Han Y, Huang S, Liu D, 2017. Global epidemiology of dengue outbreaks in 1990&#x2013;2015: a systematic review and meta-analysis. Front Cell Infect Microbiol 7: 317.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5506197</ArticleId><ArticleId IdType="pubmed">28748176</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulkarni AV, Choudhury AK, Premkumar M, Jain P, Gupta E, Sarin SK, 2019. Spectrum, manifestations and outcomes of dengue infection in individuals with and without liver disease. J Clin Transl Hepatol 7: 106.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6609843</ArticleId><ArticleId IdType="pubmed">31293909</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee K, Hsieh C-J, Lee C-T, Liu J-W, 2020. Diabetic patients suffering dengue are at risk for development of dengue shock syndrome/severe dengue: emphasizing the impacts of co-existing comorbidity(ies) and glycemic control on dengue severity. J Microbiol Immunol Infect 53: 69&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pubmed">30146413</ArticleId></ArticleIdList></Reference><Reference><Citation>Toledo J, George L, Martinez E, Lazaro A, Han WW, Coelho GE, Runge Ranzinger S, Horstick O, 2016. Relevance of non-communicable comorbidities for the development of the severe forms of dengue: a systematic literature review. PLoS Negl Trop Dis 10: e0004284.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4699776</ArticleId><ArticleId IdType="pubmed">26727113</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilder-Smith A, Ooi E-E, Horstick O, Wills B, 2019. Dengue. Lancet 393: 350&#x2013;363.</Citation><ArticleIdList><ArticleId IdType="pubmed">30696575</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x2002; Hsieh C-Y Su C-C Shao S-C Sung S-F Lin S-J Kao Yang Y-H Lai EC-C , 2019. Taiwan&#x2019;s National Health Insurance Research Database: past and future. Clin Epidemiol 11: 349&#x2013;358.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6509937</ArticleId><ArticleId IdType="pubmed">31118821</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsing AW, Ioannidis JP, 2015. Nationwide population science: lessons from the Taiwan national health insurance research database. JAMA Intern Med 175: 1527&#x2013;1529.</Citation><ArticleIdList><ArticleId IdType="pubmed">26192815</ArticleId></ArticleIdList></Reference><Reference><Citation>
Roser M, Ritchie H, 2016. Burden of Disease. Our World in Data. Available at: https://ourworldindata.org/burden-of-disease.</Citation></Reference><Reference><Citation>Fu S, Huang N, Chou YJ, 2014. Trends in the prevalence of multiple chronic conditions in Taiwan from 2000 to 2010: a population-based study. Prev Chronic Dis 11: E187.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4208993</ArticleId><ArticleId IdType="pubmed">25340359</ArticleId></ArticleIdList></Reference><Reference><Citation>
CDC T
, 2007. Research reports of Centers for Diseases Control, Department of Health, Executive Yuan, 2007 (Reference No: DOH96-DC-2021) Seroepidemiologic study of dengue virus infection in southern Taiwan (Tainan city). Available at: https://www.cdc.gov.tw/File/Get/sqrAKrJg_Uq8Ki5B0HtO3g?path=ld v1P119qxcTYg4xKooyMVeQF6u8eoK5ZR6Z2fx34y9lej3mcltZ a_P-Sj3QCbVW&amp;name=y833817dxDFUtlXLfaTlqe-wIOJw2P yPRYk--BOrv4eY11m8LUiLnALXymfdMS_Us1NjTayo0nEuOh WPz8EfVu4Bl_a9EJE9IKETRBpVv7P1B3nItZICxN66olY_ME8C.</Citation></Reference><Reference><Citation>CDC T , 2010. . Dengue Surveillance Quality Analysis. Taiwan Epidemiology Bulletin 26.</Citation></Reference><Reference><Citation>Wang S-F, Wang W-H, Chang K, Chen Y-H, Tseng S-P, Yen C-H, Wu D-C, Chen Y-MA, 2016. Severe dengue fever outbreak in Taiwan. Am J Trop Med Hyg 94: 193&#x2013;197.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4710429</ArticleId><ArticleId IdType="pubmed">26572871</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulligan K, Dixon J, Joanna Sinn C-L, Elliott SJ, 2015. Is dengue a disease of poverty? A systematic review. Pathog Glob Health 109: 10&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4445289</ArticleId><ArticleId IdType="pubmed">25546339</ArticleId></ArticleIdList></Reference><Reference><Citation>Whiteman A, Loaiza JR, Yee DA, Poh KC, Watkins AS, Lucas KJ, Rapp TJ, Kline L, Ahmed A, Chen S, 2020. Do socioeconomic factors drive Aedes mosquito vectors and their arboviral diseases? A systematic review of dengue, chikungunya, yellow fever, and Zika Virus. One Health 11: 100188.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7772681</ArticleId><ArticleId IdType="pubmed">33392378</ArticleId></ArticleIdList></Reference><Reference><Citation>de, Abreu MM, Maiorano AC, Tedeschi SK, Yoshida K, Lin T-C, Solomon DH, 2018. Outcomes of lupus and rheumatoid arthritis patients with primary dengue infection: a seven-year report from Brazil. Semin Arthritis Rheum 47: 749&#x2013;755.</Citation><ArticleIdList><ArticleId IdType="pubmed">29061443</ArticleId></ArticleIdList></Reference><Reference><Citation>Knapp S, 2013. Diabetes and infection: is there a link? A mini-review. Gerontology 59: 99&#x2013;104.</Citation><ArticleIdList><ArticleId IdType="pubmed">23182884</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x2002; Lee I-K Hsieh C-J Chen R-F Yang Z-S Wang L Chen C-M Liu C-F Huang C-H Lin C-Y Chen Y-H , 2013. Increased production of interleukin-4, interleukin-10, and granulocyte-macrophage colony-stimulating factor by type 2 diabetes&#x2019; mononuclear cells infected with dengue virus, but not increased intracellular viral multiplication. BioMed Res Int 2013: 965853.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3773921</ArticleId><ArticleId IdType="pubmed">24078930</ArticleId></ArticleIdList></Reference><Reference><Citation>Htun NSN, Odermatt P, Eze IC, Boillat-Blanco N, D&#x2019;Acremont V, Probst-Hensch N, 2015. Is diabetes a risk factor for a severe clinical presentation of dengue? Review and meta-analysis. PLoS Negl Trop Dis 9: e0003741.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4409149</ArticleId><ArticleId IdType="pubmed">25909658</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas EA, George J, Sruthi D, Vineetha N, Gracious N, 2019. Clinical course of dengue fever and its impact on renal function in renal transplant recipients and patients with chronic kidney disease. Nephrology (Carlton) 24: 564&#x2013;568.</Citation><ArticleIdList><ArticleId IdType="pubmed">29607577</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>